Evidence map›Paper›PMID 25232340›Full record

ArticleCase reports in ophthalmology2014

Recovery of visual function after administration of dabigatran etexilate.

Carl-Ludwig Schönfeld, Marie Fischer, Peter Distelmaier, Sebastian Philipp, Patrick Paquet, Katharina Haller, Linda Meyer

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carl-Ludwig SchönfeldHerzog Carl Theodor Eye Clinic, Munich, Germany.
Marie FischerHerzog Carl Theodor Eye Clinic, Munich, Germany.
Peter DistelmaierHerzog Carl Theodor Eye Clinic, Munich, Germany.
Sebastian PhilippHerzog Carl Theodor Eye Clinic, Munich, Germany.
Patrick PaquetHerzog Carl Theodor Eye Clinic, Munich, Germany.
Katharina HallerHerzog Carl Theodor Eye Clinic, Munich, Germany.
Linda MeyerHerzog Carl Theodor Eye Clinic, Munich, Germany.
Blindeninstitutsstiftung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 46-year-old Caucasian female underwent pars plana vitrectomy (ppv) for retinal detachment. After the procedure, the patient could only distinguish hand movements; the condition was tentatively diagnosed as nonarteritic anterior ischemic optic neuropathy. Conventional treatment with systemic corticosteroids and acetylsalicylic acid was ineffective and yielded substantial steroid-related side effects. Additional administration of 2 × 110 mg dabigatran etexilate (Pradaxa(®)), a novel direct thrombin inhibitor, resulted in a prompt and marked improvement of visual acuity, which indicated improved blood flow in the central vessels of the optic nerve. Dabigatran etexilate may provide a promising alternative for the treatment of postprocedural vision loss after ppv.

Indexed as

Antithrombotic agentsComplications, postoperativeDabigatran etexilatePars plana vitrectomyVisual loss

Identifiers

PMID25232340
PMCPMC4163691
OpenAlexW2011286715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.